Skip to main content
Clinical Trials/CTRI/2019/05/018985
CTRI/2019/05/018985
Completed
Phase 4

Anesthetic efficacy of supplemental buccal infiltration with 4% Articaine, after a failed inferior alveolar nerve block or Gow Gates nerve block with 2% Lignocaine in mandibular molars diagnosed with symptomatic irreversible pulpitis-A Randomized Double blind trial

Kanaga priyaa V0 sites114 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Kanaga priyaa V
Enrollment
114
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 16, 2019
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Kanaga priyaa V

Eligibility Criteria

Inclusion Criteria

  • Systemically healthy patients
  • patients with symptomatic irreversible pulpitis in mandibular molars
  • Absence of any periapical radiolucency on radiograph except for a widening of periodontal ligament
  • A vital pulp at access cavity preparation
  • Ability to understand the use of pain scales

Exclusion Criteria

  • Allergy to local anesthetics, pregnancy, the use of any medications such as sedatives,antianxiety,antidepressants or analgesics that might influence pain assessment, the presence of active pathosis in the area of injection, the inability to give written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials